July 28th, 2025: Plaintiffs Seek Mass Tort Designation for Ozempic Vision Loss Cases in New Jersey Litigation surrounding Ozempic and Wegovy is expanding beyond gastrointestinal side effects, with over 30 plaintiffs now alleging the drugs caused vision loss linked to nonarteritic anterior ischemic optic neuropathy (NAION)a condition that may result in permanent blindness
Clinical studies underscore a weight loss range of 15 to 20 percent with lifestyle modifications, ranking semaglutide among the most effective weight loss medications
[4] [5] For Wegovy specifically, pregnancy is a contraindication, and women of childbearing potential should use effective contraception during treatment
J Biol Chem 179:12451254 Buonocore D, Grosini M, Giardina S, Michelotti A, Carrabetta M, Seneci A, Verri M, Dossena M, Marzatico F (2016) Bioavailability study of an innovative orobuccal formulation of glutathione